TCL Archive CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans. November 5, 2004
TCL Archive Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices September 3, 1993
